In humans, S100A11 expression was also strongly correlated with the cancer stage, with the patient’s survival probability and secretion of this isoform by hepatic cancer cells highlighting S100A11 as a potential prognostic and diagnostic circulating biomarker for HCC [65,144]. Here, S100A11 is linked to hepatocellular carcinoma.